Outset Medical Board Changes: New Director Appointed, Szyman Steps Down
Company Announcements

Outset Medical Board Changes: New Director Appointed, Szyman Steps Down

An announcement from Outset Medical (OM) is now available.

Catherine Szyman stepped down from the Board of Directors at Outset Medical to prepare for her new role as CEO of a spinoff from Edwards Lifesciences, with no disagreements cited. Brent D. Lang, with a rich background in leadership including his tenure as CEO of Vocera Communications, has been appointed to fill her position. Lang, recognized as an independent director, will adhere to the company’s compensation policy for non-employee directors and will be indemnified under standard company agreements. This boardroom shuffle aims to maintain Outset Medical’s strategic direction and uphold its governance standards.

For an in-depth examination of OM stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskOutset Medical, Inc. Announces Solid Q3 2024 Results
TheFlyOutset Medical management to meet virtually with BTIG
Sirisha BhogarajuClass Action Lawsuit Against Outset Medical (NASDAQ:OM)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App